FDA Officials Discuss Overhauling Agency In NEJM Perspective

Main Category: Regulatory Affairs / Drug Approvals
Also Included In: Public Health
Article Date: 27 May 2009 - 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:3 stars

3 (1 votes)


"The FDA as a Public Health Agency," New England Journal of Medicine: In the perspective, FDA Commissioner Margaret Hamburg and Joshua Sharfstein, principal deputy commissioner of the agency, provide "a broad overview" of how they plan to "embrace" the agency's mission to protect the public's health. Hamburg and Sharfstein discuss their plans to work with other U.S. agencies, such as NIH, CDC and CMS, as well as challenges posed by globalization. In addition, they write that they will work to improve transparency at FDA (Hamburg/Sharfstein, NEJM, 5/26).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.

© 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Article adapted by Medical News Today from original press release.
Visit our regulatory affairs / drug approvals section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Kaiser. "FDA Officials Discuss Overhauling Agency In NEJM Perspective." Medical News Today. MediLexicon, Intl., 27 May. 2009. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/151531.php>

APA
Kaiser. (2009, May 27). "FDA Officials Discuss Overhauling Agency In NEJM Perspective." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/151531.php.

Please note: If no author information is provided, the source is cited instead.


Regulatory Affairs / Drug Approvals

Most Popular Articles



Follow Our Regulatory Affairs News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Regulatory Affairs / Drug Approvals Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »